“Endothelin-1 indicates unfavorable prognosis in primary high-grade non-muscle-invasive urothelial bladder cancer”, Arch Ital Urol Androl, vol. 93, no. 2, pp. 143–147, Jun. 2021, doi: 10.4081/aiua.2021.2.143.